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Abstract 
 This study compares the injecting and sexual risk-behaviour of young injectors, with 
injectors over the age of 25. All respondents presented for the first time at the Merchants’ 
Quay Health Promotion Unit between May 1st 1997 and February 28th 1998. Analysis 
revealed that the young injectors were significantly more likely to report recently borrowing 
and lending used injecting equipment, and injecting paraphernalia. Regarding sexual risk 
behaviour, younger respondents were proportionately more likely to report being sexually 
active, having multiple sexual partners, and having a regular partner who is an injecting drug 
user. However, they were significantly more likely than older clients to report condom use. 
The suggestion is that the harm minimisation message, which reached its zenith in the early 
1990s, has now been somewhat de-emphasised in both policy and practice. Consequently, it is 
not reaching the young injectors who have recently initiated intravenous drug use. Additional 
strategies are needed to target this group of drug users, in order to promote positive 
behaviour changes. 
Introduction 
During the early 1980s Dublin experienced an unprecedented increase in illicit drug use and in 
particular intravenous heroin use1. This increase coupled with the growing international 
awareness of the risks of Human Immunodeficiency Virus (HIV) transmission through the shared 
use of infected injecting equipment, led to a shift in Irish drug policy. There was a move from the 
traditional abstinence orientated model of drug treatment to a more pragmatic harm reduction 
approach2, which received official endorsement in the 1991 Government Strategy to Prevent 
Drug Misuse3. The reduction of drug-related harm, aims at achieving “intermediate goals” other 
than abstinence, such as safer drug use and avoiding health risks4, through a range of low 
threshold, outreach and crisis intervention services. 
 The Merchant’s Quay Project established its Health Promotion Unit in 1992 to provide a 
model for working with drug injectors engaging in risky behaviour which concentrates on 
eliminating or reducing these risks. The name of the Unit reflects that it was not intended as a 
‘single’ intervention, the exchange of new injecting equipment for used equipment. Rather, the 
Unit provides a range of services, all of which are considered to be an essential aspect of health 
promotion among injecting drug users (IDU’s). 
 Some attempts have been made to measure the impact of various harm minimisation 
strategies on the levels of risk behaviour in drug injectors in Dublin. For example Williams et al 
(1990)5 reported on the levels of risk behaviour among drug users enrolled in a methadone 
programme. Johnson et al (1994)6 measured the level of injecting and sexual risk behaviours of 
attendees at a Dublin syringe exchange. More recently Dorman et al (1997)7 illustrated that 
within their sample of in-treatment and out of treatment IDU’s over half of the respondents 
reported sharing injecting equipment in the six months prior to interview, and 53 per cent 
reported never using condoms. 
 The main objective of this paper is to provide some empirical data about younger injectors 
(i.e. under 25 yr of age) levels of risk behaviour by comparing this client group with a cohort of 
older injectors. Young injectors are the focus of the study primarily because of the increase in the 
numbers of young Irish drug users presenting for treatment, which has been highlighted in the 
1997 Annual Report of the European Monitoring Centre for Drugs and Drug Addiction8. 
According to this Report, Ireland is among a handful of countries consistently reporting increases 
in heroin use by new groups of young people. This was emphasised by the fact that the average 
age of drug users in treatment in Ireland was the lowest in Europe at 23.6 yr. Just over 65 per cent 
of individuals treated for drug problems in Ireland were under the age of 25, compared with only 
43 per cent in the United Kingdom. 
 This paper expands on the findings of previous research on risk behaviour among drug 
injectors and presents baseline data on the injecting risk behaviour of young injectors compared 
with older injectors. This study has the advantage of not only having a large proportion of 
younger injectors (0.63), thereby permitting the comparison, but also having a large proportion of 
recent injectors (0.36) and female injectors (0.25), sub-groups under-represented in many studies 
of IDU’s. 
Method 
Information on all new clients at the Health Promotion Unit was collected by means of an 
Intervention Sheet at first attendance. This questionnaire is highly structured and gathers self-
reported information on client’s demographic characteristics and baseline information on clients’ 
HIV risk behaviour, with respect to injecting drug use and sexual behaviour. Self-report of sexual 
behaviour9 and drug use behaviour10 in IDU’s has been demonstrated to be of acceptable 
reliability and validity. A similar questionnaire is repeated 3 months later in order to measure 
changes in clients to help assess the impact of Merchant’s Quays Health Promotion Unit. The 
results of this follow-up will be reported at a later date. 
 A number of steps were taken in order to attempt to reduce non-response. The Intervention 
Sheet was piloted twice on a sample of clients and their comments on content and question 
wording were taken into consideration. This ensured that there was no ambiguity over the 
terminology used. All information on clients was collected by trained staff at the Merchant’s 
Quay Project. Hence maximising the rapport between interviewer and client. The Intervention 
Sheets were completed in the Exchanges in the Health Promotion Unit, which have been designed 
to create a permissive non-threatening environment. The purpose of the Intervention Sheets in 
evaluating the Unit and its therapeutic benefits in helping workers to get a feel for the clients 
history and circumstances were explained to all new attenders. No pressure was placed on any 
clients to complete the Intervention Sheet, and it was made clear, that regardless they would 
receive the same quality of service. Clients were assured that the information provided would be 
kept confidential and would not jeopardise provision of treatment or other interventions offered 
by the Merchant’s Quay Project. 
 The data set used here represents the total population of new clients attending the Health 
Promotion Unit (n=770) within the specified time frame, between May 1st 1997, and February 
28th 1998. No client presenting within the time period refused to comply. Percentages are based 
on the above returns or valid responses adjusted for missing data. Missing data includes 
information not collected by staff at the project and non-response by clients. In order to examine 
the differences between Group I young injectors (<25 yr of age) and Group II older injectors (>25 
yr of age), for continuous variables such as, age of first drug use, age at first injecting and length 
of time injecting, T-tests were conducted. Chi-square analysis was conducted on categorical 
variables to test for differences between groups. 
Results 
Drug Using Characteristics 
 The major drug using characteristics of the sample are presented and compared in Table I 
(categorical variables) and Table II (continuous variables). Table I shows that younger injectors 
were significantly more likely to be female than clients over the age of 25. There was no 
difference between the 2 groups in reported current contact with other drug treatment services. 
However, clients over the age of 25 were significantly more likely to report having undergone 
detoxification at some point in their drug taking career, which may indicate prior contact with 
drug treatment services. 
 As regards drug using history. Table II shows that clients under the age of 25 started using 
illicit drugs at a significantly younger age than clients over the age of 25. The mean age of first 
drug use for the younger respondents was 16.99, and for the older clients it was 22.57. Group I 
respondents were significantly more likely to report having 
TABLE I 
Drug Using Characteristics by Age (categorical variables) 
AGE STATUS Variables 
GROUP I 
<25 years old 
(n=485) 
GROUP II 
>25 years old 
(n=285) 
Chi- 
Square 
p value 
Gender: male 69.5%(337) 84.6%(241) 21.80 <0.000001 
 female 30.5%(148) 15.4%(44)   
% in treatment 18.6%(90) 22.1%(63) 1.35 NS 
% had detox 47.6%(231) 59.6%(170) 9.86 <0.01 
% Smoked prior to IV 93.1%(442/475) 75.8%(213/281) 45.39 <0.000001 
% Using heroin* 93.4%(453) 88.1%(251) 6.23 <0.05 
%IDU* 91.1%(442) 88.1%(251) 1.47 NS 
% Poly-drug use* 67.4%(321/476) 63.5%(179/282) 1.23 NS 
% Daily IV use* 82.1%(398) 78.5%(219) 2.65 NS 
% Living with IDU 27.4%(132/482) 29.5%(83/281) 0.40 NS 
Total number of subjects are specified where there are missing data. 
* Refers to the four weeks prior to contact with the Health Promotion Unit. 
 
 
 
TABLE II 
Drug Using Characteristics by Age (Continuous variables) 
AGE STATUS Variables 
GROUP I 
<25 years old 
(n=485) 
Mean (SD) 
GROUP II 
>25 years old 
(n=285) 
Mean (SD) 
 
 
 
T-Value 
 
 
 
p value 
Age first drug use 
Time smoking* 
Age first IV Time 
IV* 
16.99(2.5) 
98.58(83.9) 
18.94(2.4) 
65.71(87.71) 
22.57(5.7) 
104.22(134.5) 
24.81(5.9) 
269.08(333.64) 
-15.00 
-0.64 
-15.77 
-10.03 
<0.0005 
NS 
<0.0005 
<0.0005 
* The mean times smoking and injecting are expressed in weeks. 
smoked illicit drugs prior to their initiation into intravenous drug use. As illustrated in Table II 
there was no statistically significant differences between client groups in the length of time they 
reported smoking. However, respondents under the age of 25 initiated intravenous drug use at a 
significantly younger age than Group II respondents. As expected the older clients had 
significantly longer injecting careers, than did clients under the age of 25. 
 There was little reported difference in the current drug use of young injectors, and older 
injectors. Although, Table I illustrates that the young respondents were significantly more likely 
to report using heroin as their primary drug. There was no statistically significant difference 
between Group I and Group II clients in reported poly-drug use, and daily intravenous drug use 
over the four weeks prior to contact. 
Injecting and Sexual Risk-Taking Behaviour 
 Table III presents and compares the injecting and sexual risk taking behaviour of Group I 
and Group II clients. Although the difference was not statistically significant, younger clients 
despite their shorter injecting histories were proportionately more likely to report having shared 
needles/syringes at some point in time. A further- distinction in the sharing of injecting 
equipment was made, that is in the recent borrowing and lending of used needle and syringes. 
Younger clients proved to be significantly more likely to report having both lent and borrowed 
used needles and syringes in the 4 weeks prior to first contact. Table III illustrates that of those 
clients with a sexual partner, the younger injectors were significantly more likely to report having 
a sexual partner who was also an IDU. Although the difference was not statistically significant, 
this client group was proportionately more likely to report sharing injecting equipment with their 
injecting sexual partner. The younger injectors in this cohort were also significantly more likely 
to report the recent sharing of injecting paraphernalia (i.e. spoons and filter); 64.3 per cent of 
Group I clients report such behaviour, compared with less than half of the clients over the age of 
25. 
 
 
 
 
TABLE III 
Injecting and Sexual Risk-taking Behaviour by Age Status 
AGE STATUS Variables 
GROUP I 
<25 years old 
(n=485) 
GROUP II 
>25 years old 
(n=285) 
Chi- 
Square 
p value 
% Ever shared     
needles/syringes 56.4% (268/475) 53.0%(148/279) 0.80 NS 
% lent needles/syringes* 18.1% (86/475) 12.2%(34/278) 2.9 <0.05 
% borrowed needles/     
syringes* 26.7%(127/475) 17.3%(48/277) 8.67 <0.01 
% shared 
needles/syringes 
    
with sexual partner* 25.2%(78/310) 19/1%(41/189) 2.48 NS 
% shared IV     
paraphernalia* 64.3%(305/474) 43.8%(121/276) 24.0 <0.000001 
% inject self 73.3%(341/465) 85.9%(237/276) 15.86 <0.0001 
% sexually activea 77.1%(374) 75.4%(215) 0.28 NS 
% multiple sexual     
partnersa 28.5%(135/474) 21.3%(60/282) 4.79 <0.05 
% regular sexual partner 66.3%(313/472) 68.4%(193/282) 0.36 NS 
% IDU Partner1 41.9%(131/313) 33.6%(65/193) 3.66 <0.05 
% use condoms 69.1%(328/475) 58.2%(164/282) 9.23 <0.000001 
%HIV test 38.4%(179/466) 60.8%(166/273) 34.68 <0.000001 
% vaccination Hep B 10.9%(52/473) 30.2%(84/278) 44.25 <0.000001 
*This refers to the four weeks prior to first contact 
aThis refers to the three months prior to first contact 
1This population relates to the clients who reported having a regular partner 
 Although the younger respondents were more likely to engage in injecting risk behaviour 
than older clients, as illustrated in Table III, they are significantly less likely to report having had 
a HIV test, or to have had a vaccination against Hepatitis B. Analysis also revealed that younger 
injectors were significantly less likely to be aware of their Hepatitis B (X2=23.58; df=2; 
p<0.00001) and C status (X2=24.75; df=2; p<0.0001), and whether they had jaundice (X2 =27.13; 
df=2; p<0.0001), compared with clients over the age of 25. 
 Regarding sexual risk behaviour. Table III illustrates that the majority of both Group I and 
Group 11 clients reported being sexually active in the 3 months prior to contact with the Health 
Promotion Unit. Younger clients were significantly more likely to report having had multiple 
sexual partners in that time period. In their favour, respondents under the age of 25 were 
significantly more likely to report using condoms. 
Discussion 
The importance of this study is in the information afforded by the comparison of the group of 
under 25 yr old (n=485) and over 25 yr old (n=285) first time presenters at the Merchant’s Quay 
Health Promotion Unit. The research findings present serious cause for concern as they depict 
high levels of risk behaviour both in terms of injecting and in terms of sexual practices. Despite 
the increase in the number of drug treatment programmes and the extensive public HIV 
prevention campaigns there has not been a diminution in the risk behaviour amongst this client 
group. Areas of particular concern include the very young age that respondents under 25 reported 
initiating intravenous drug use (mean 18.94), the presence of a large proportion of young female 
injectors (0.25), and the lack of awareness among the younger respondents of their HIV and 
Hepatitis B or C status given their level of risk behaviours. 
 International research has identified factors other than youth itself11, which are associated 
with high levels of injecting and sexual, risk behaviour. Included among these are poly-drug 
use12, having a sexual partner who is an IDU13, having multiple sexual partners, and living with 
an IDU14. This research illustrated that significant proportions of young injectors fall into the 
aforementioned categories. 
 The research findings also confirm the high levels of risk behaviour among IDU’s recorded 
by previous Irish studies5,6,7, but in comparing the younger and older cohorts it highlights the 
higher level of risk behaviour among the younger groups. One might expect that the less 
experienced drug user by virtue of their age, shorter drug taking histories, and lack of engagement 
with services, might be prone to more risk taking behaviour. However, this raises another set of 
questions about the effectiveness of prevention and awareness programmes in targeting young 
drug users or potential young drug users. 
 The study indicates that the younger respondents were slightly more likely to report having 
shared needles and syringes than the older clients; 56.4 per cent of the younger group shared as 
against 53 per cent of the older group. This level of sharing is consistent with a 1997 study by 
Dorman et al, which recorded 55.7 per cent as having reported sharing equipment7. A more 
detailed examination of sharing behaviour illustrates that 26.7 per cent of the younger injectors 
reported the recent borrowing of used injecting equipment. The lending and borrowing of 
needles/syringes differ markedly in terms of levels of personal risk and risk of HIV and Hepatitis 
transmission15, in that injectors who use others’ injecting equipment potentially risk becoming 
infected (or re-infected) with HIV or Hepatitis. This high level of borrowing has serious public 
health implications. 
 Previous studies have shown that drug users are highly sexually active16 and that condom 
use among this group is relatively low17. Our research findings reveal that both age groups 
reported being sexually active, 77.1 per cent of the younger group and 75.4 per cent of the older 
group, with 28.5 per cent of the younger group and 21.3 per cent of the older group having 
multiple partners. However, the younger group reported significantly higher condom use than the 
older group, 69.1 per cent as against 58.2 per cent. International research corroborates the 
position that sexual behaviour is more difficult to change than needle sharing behaviour18. 
However this study raises challenging questions in this regard. It could be argued that information 
campaigns regarding safer sex have had a more significant impact on the younger age group than 
those campaigns pertaining to safer drug use practices. This is especially evident in the 
comparisons of sharing injecting paraphernalia. Forty six per cent of the older group reported the 
sharing of injecting paraphernalia (i.e. spoons and filters) as opposed to 64.3 per cent of the 
younger group. As the transmission of Hepatitis C and HIV has been linked to these sharing 
practices14 the implications are obviously very serious. The younger group were also significantly 
less likely to have tested for HIV, 38.4 per cent as against 60.8 per cent of the older group and 
significantly less likely to have been vaccinated against hepatitis B, 10.9 per cent against 30.2 per 
cent of the older group. 
 In conclusion our research findings reveal alarming risk taking behaviours among younger 
drug users. These behaviours relate to sexual activity and the sharing of injecting equipment and 
have serious implications for the transmission of HIV and Hepatitis among the drug using 
population, and potentially into the wider population. There are subsequent implications for the 
drug treatment facilities, health services, the police and the criminal justice system over the 
coming years. These systems have not yet had to cope with a large number of young drug users, a 
significant proportion of whom will be women. 
 Our findings appear to indicate that previous and contemporary drug prevention and 
awareness raising campaigns have not succeeded in impacting sufficiently to change the risk 
behaviour of young drug users. There are clear messages emerging from this research with regard 
to policy formulation and service provision. In the first instance young drug users need to be 
identified at an early stage in their using cycle and their information needs to be established and 
addressed. The emphasis on harm reduction should be reiterated for current young drug users and 
a range of accessible locally delivered and coordinated services should be established. This will 
ensure that young drug users are aware of the consequences of their risk behaviours and may 
choose to engage in safer practices to minimise that risk. On a wider scale, any significant 
consequences will hopefully result in a decrease in the transmission of HIV and Hepatitis C 
representing a very positive step forward. 
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